Additionally, improved glycaemic control may positively influence pre-existing diabetes-related skin conditions such as acanthosis nigricans (darkened skin patches) or diabetic dermopathy
Sources: - Lilly's next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial (Published: 2025-12-11) - - American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 Update - PubMed (Published: 2025-01-01) - - Introduction and methodology: Standards of Care in Overweight and Obesity2025 | BMJ Open Diabetes Research & Care (Published: 2025-05-23) - #ObesityMedicine #WeightLoss #Retatrutide #TripleAgonist #GLP1 #ChronicDisease #HealthcareInnovation #Pharma #CardiovascularHealth #ObesityTreatment To view or add a comment, sign in Obesity, Metabolic Syndrome, and Osteoarthritis Require Integrative Understanding and Management by Mocanu, V., et al
Wing MR, Snyder JT, Sondek J, Harden TK
It also helps minimize muscle loss that can happen when youre eating on a GLP-1 medication
Peptides are short chains of amino acids, which are the building blocks of protein
Can genetic testing help me choose between semaglutide and tirzepatide if I'm on blood thinners
